Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
This study will evaluate the safety and tolerability and Aß-specific antibody response of CAD106 in patients with mild to moderate Alzheimer's Disease. Patients also had a 2 year follow-up to assess disease progression where no drug was administered.
Critère d'inclusion
- Alzheimer's disease